Template for sharing EMA documents by Industry to support reliance
Template for sharing EMA documents by Industry to support reliance
Template for sharing EMA documents by Industry to support reliance
Human medicines European public assessment report (EPAR): Abilify Maintena, aripiprazole, Date of authorisation: 14/11/2013, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Date of authorisation: 24/09/2025, Status: Authorised
Referral: Sodium oxybate-containing syrup and oral solution for alcohol dependence, sodium oxybate Article 31 referrals Under evaluation, 28/10/2025
Human medicines European public assessment report (EPAR): Keppra, levetiracetam, Date of authorisation: 29/09/2000, Revision: 57, Status: Authorised
Agenda of the PRAC meeting 27 - 30 October 2025
EMEA-002712-PIP01-19-M01
EMEA-002287-PIP01-17-M03
Human medicines European public assessment report (EPAR): Fanskya, Mozafancogene autotemcel, Status: Application withdrawn